BCEIE › News › DCMSHRIRAM

M&A

DCM Shriram: The Board Approved Equity contribution of upto Rs 50Cr in Shriram Teknor Ltd. Details are as per attachment

DCM Shriram (DCMSHRIRAM) filed a disclosure titled "The Board Approved Equity contribution of upto Rs 50Cr in Shriram Teknor Ltd. Details are as per attachment". The company is valued at about ₹15,041 crore.

BCEIE News Desk · Published 26 Oct 2026, 06:08 pm IST · Filing received 26 Oct 2026, 05:52 pm IST

What happened

DCM Shriram (DCMSHRIRAM) filed a disclosure with the exchanges on 26 October 2026 at 05:52 PM titled "The Board Approved Equity contribution of upto Rs 50Cr in Shriram Teknor Ltd. Details are as per attachment".

How big is it?

At ₹50 crore, the deal is equal to about 0.3% of the company's market value of ₹15,041 crore.

Company snapshot

DCM Shriram is a small-cap company in the Diversified sector, with a market value of about ₹15,041 crore.

The stock last traded at ₹964.5, against a 52-week range of ₹886.3–₹1,409 (31.6% below the high).

Before this filing the shares had moved −1.5% over the month and −4.1% over three months. Average daily turnover over the last 20 sessions was about ₹20.37 crore.

Promoters held 66.52% at the end of Q1 FY27. Foreign institutions owned 3.89% and domestic institutions 8.46%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY263,455113.47.27
Q2 FY263,43215810.14
Q3 FY264,003212.113.59
Q4 FY263,373369.923.71
Q1 FY273,785693.444.72

What history shows

This is not the company's first m&a disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.

After those filings, the stock gained 1.4% on average the next trading day and was up 2.2% on average after five days (2 filings with price data).

Market-wide, 2,147 m&a filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 49% rising.

Past reactions describe what happened before; they are not a forecast.

Earlier filings of this kind
DateFilingNext day5 days
17 Jul 2026M&A+1.5%+1.0%
30 Jun 2026M&A+1.4%+3.5%

What to watch

  • Regulatory approvals, completion of the deal and its effect on revenue and margins.
  • 26 October 2026: Board meeting — Financial Results/Dividend.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on DCM Shriram Limited